Suzan A Rattan
Quick facts
Marketed products
- Intracameral Moxifloxacin 0.1% · Ophthalmology / Infectious Disease
Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in bacteria.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: